Detalhe da pesquisa
1.
PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells.
Nature
; 610(7930): 161-172, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171284
2.
Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies.
Clin Cancer Res
; 29(21): 4449-4463, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379429
3.
Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688559
4.
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy.
Sci Transl Med
; 11(496)2019 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31189721
5.
CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies.
Clin Cancer Res
; 24(19): 4785-4797, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29716920